SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $36,000 | -98.6% | 327,995 | -78.5% | 0.00% | -100.0% |
Q3 2018 | $2,592,000 | -6.0% | 1,526,271 | -3.7% | 0.00% | 0.0% |
Q2 2018 | $2,756,000 | +15.2% | 1,584,883 | +21.2% | 0.00% | 0.0% |
Q1 2018 | $2,392,000 | -50.4% | 1,308,043 | -39.5% | 0.00% | -66.7% |
Q4 2017 | $4,818,000 | -30.3% | 2,161,529 | -9.3% | 0.00% | -40.0% |
Q3 2017 | $6,912,000 | +48.4% | 2,384,000 | +127.7% | 0.01% | +66.7% |
Q2 2017 | $4,657,000 | +224.8% | 1,046,905 | +239.9% | 0.00% | +200.0% |
Q1 2017 | $1,434,000 | +80.2% | 307,999 | +135.1% | 0.00% | 0.0% |
Q4 2016 | $796,000 | -83.9% | 131,004 | -85.4% | 0.00% | -66.7% |
Q3 2016 | $4,939,000 | +50.1% | 896,493 | +3.4% | 0.00% | +50.0% |
Q2 2016 | $3,291,000 | +91.9% | 866,716 | +39.3% | 0.00% | +100.0% |
Q1 2016 | $1,715,000 | -57.9% | 622,044 | -13.4% | 0.00% | -66.7% |
Q4 2015 | $4,073,000 | -21.5% | 718,450 | -26.6% | 0.00% | -25.0% |
Q3 2015 | $5,188,000 | +719.6% | 979,132 | +1181.7% | 0.00% | – |
Q2 2015 | $633,000 | +99.1% | 76,396 | +9.9% | 0.00% | – |
Q1 2015 | $318,000 | -6.2% | 69,506 | -37.8% | 0.00% | – |
Q4 2014 | $339,000 | +153.0% | 111,781 | +129.8% | 0.00% | – |
Q3 2014 | $134,000 | +8.1% | 48,642 | +58.0% | 0.00% | – |
Q2 2014 | $124,000 | -79.3% | 30,785 | -72.8% | 0.00% | – |
Q1 2014 | $599,000 | +8.7% | 113,019 | +15.3% | 0.00% | – |
Q4 2013 | $551,000 | -75.7% | 97,998 | -80.3% | 0.00% | -100.0% |
Q3 2013 | $2,270,000 | – | 497,145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|